Fulgent Genetics, Inc. FLGT
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2016-09-28
Chart by TradingView
3/9
Piotroski F — financial health
14.32
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $322.7M | $283.5M | $289.2M | $619.0M | $992.6M |
| Gross profit | $130.9M | $107.2M | $104.5M | $366.9M | $777.1M |
| Operating income | -$91.1M | -$73.9M | -$195.5M | $178.5M | $676.0M |
| Net income | -$60.5M | -$42.7M | -$167.8M | $143.4M | $507.4M |
| Operating cash flow | -$101.6M | $21.1M | $27.0M | $253.5M | $538.6M |
| Free cash flow | -$124.2M | -$19.3M | $4.8M | $234.7M | $514.8M |
| Total assets | $1.2B | $1.2B | $1.2B | $1.4B | $1.3B |
| Total liabilities | $106.8M | $90.8M | $102.0M | $116.2M | $112.8M |
| Shareholders' equity | $1.1B | $1.1B | $1.1B | $1.3B | $1.2B |
| Ratios | |||||
| Gross margin | 40.6% | 37.8% | 36.1% | 59.3% | 78.3% |
| Operating margin | -28.2% | -26.1% | -67.6% | 28.8% | 68.1% |
| Net margin | -18.8% | -15.1% | -58.0% | 23.2% | 51.1% |
| FCF margin | -38.5% | -6.8% | 1.7% | 37.9% | 51.9% |
| Return on assets | -5.0% | -3.5% | -13.6% | 10.3% | 39.7% |
| Return on equity | -5.5% | -3.8% | -14.8% | 11.3% | 43.5% |
| Current ratio | 6.48 | 4.85 | 6.96 | 7.13 | 5.81 |
| Revenue growth | 13.8% | -2.0% | -53.3% | -37.6% | 135.4% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 18,000 | $286,200 |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 14.32 (safe)
- Working capital / assets 0.384
- Retained earnings / assets 0.437
- EBIT / assets -0.075
- Equity / liabilities 10.362
Sector peers
GOOG · MSFT · META · BABA · DIS · HCA · all Services →
Source: SEC EDGAR filings · CIK 0001674930 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.